Pediatrics

Weight management in children and adolescents with obesity requires unique sensitivity to the physical and emotional needs of these vulnerable pediatric patients.

RSV is back for the 2022-23 respiratory virus season and is unfamiliar to many. Click through this quick collection of myths already in circulation to prepare.

Semaglutide 2.4 mg (Wegovy) weight loss benefits in adolescents mirror those seen in adults, according to phase 3a trial findings presented at ObesityWeek® 2022.

Topline phase 3 trial data showed 81.8% efficacy for the maternal vaccine against severe RSV-related illness in infants from birth through first 90 days of life.

For the first time, the task force recommended screening children aged 8 and older for anxiety in primary care settings.

The FDA amended EUAs for omicron-adapted vaccines from both Pfizer and Moderna, authorizing the shots for children and adolescents.

The noninvasive, easily administered tool was able to predict at age 3 years children who would be diagnosed with asthma at age 5 years.

Findings show that increased consumption of candy among adolescents was linked to a 31% increase in intake of all other ultraprocessed foods.

Refractory adult misbeliefs about vaccine safety have increased reluctance to vaccinate US children aged 5-11 years, according to an Annenberg Public Policy center survey.

Children with obesity enrolled in the FitTastic study group had more favorable BMI patterns compared to control group, according to longitudinal effectiveness study.

Adolescents with severe obesity who underwent bariatric surgery before age 22 lost 31.1% body weight and kept it off over a decade later, showed new study.

Youth newly diagnosed with T2D also were metabolically sicker, with higher HbA1c, serum glucose levels, and BMI at presentation.

Pediatric COVID-19 vaccination can be tricky as vaccine antigen levels vary by age groups. These 3 patient scenarios may help clarify.

Refresh your memory on refugee immunization recommendations with a 2-question quiz based on a patient scenario.

Understanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.

Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.

The CDC is encouraging parents of children in this age group to first finish a primary vaccination series, saying only 28% now are in that category.

The proportion of overweight, obesity, or severe obesity increased from 38% to 45% among 4500 young people seen in a primary care network where most receive public insurance.

Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.

The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.

How much do you know about diphtheria and the vaccine? Answer these 2 questions to find out.

SAMPLE: A 7-year-old child newly immigrated to the US has not received any previous pneumococcal vaccines. What does the CDC recommend for this child?

How can clinicians help parents of school-aged children foster wellbeing now that pediatric COVID-19 vaccination and booster doses are recommended?

How did up-to-date pediatric routine vaccination rates fare during the COVID-19 pandemic compared to before?

How do low socioeconomic status and adverse childhood experiences tie into pediatric obesity? Here, an overview for practitioners.